1
Clinical Trials associated with Autologous RCC Tumor Derived Cells(Genzyme)Phase 1/2 Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusion in Patients With AJCC Stage IV Renal Cell Carcinoma
The primary purpose of this study is to determine the safety of injections prepared from donor blood cells fused to a patient's own tumor cells which are then used to treat advanced (Stage IV) kidney cancer (renal cell carcinoma or RCC). The study will also explore the effect the injections have on the size of the tumor and the response in the patient's immune system following administration.
100 Clinical Results associated with Autologous RCC Tumor Derived Cells(Genzyme)
100 Translational Medicine associated with Autologous RCC Tumor Derived Cells(Genzyme)
100 Patents (Medical) associated with Autologous RCC Tumor Derived Cells(Genzyme)
100 Deals associated with Autologous RCC Tumor Derived Cells(Genzyme)